GOLGA2/GM130, cis-Golgi Matrix Protein, is a Novel Target of Anticancer Gene Therapy

Achievement of long-term survival of patients with lung cancer treated with conventional chemotherapy is still difficult for treatment of metastatic and advanced tumors. Despite recent progress in investigational therapies, survival rates are still disappointingly low and novel adjuvant and systemic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chang, Seung-Hee, Hong, Seong-Ho, Jiang, Hu-Lin, Minai-Tehrani, Arash, Yu, Kyeong-Nam, Lee, Jae-Ho, Kim, Ji-Eun, Shin, Ji-Young, Kang, Bitna, Park, Sungjin, Han, Kiwon, Chae, Chanhee, Cho, Myung-Haing
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2012
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3498792/
https://ncbi.nlm.nih.gov/pubmed/22735382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.125
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi